SCHEMBL60931

SCHEMBL60931

O=C(CS)OCCCCOC(=O)CS

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.46
TSHR P16473 3/20 0.46
HSD17B10 Q99714 1/20 0.46
RAD52 P43351 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP3A4 P08684 1/20 0.39
FAAH O00519 1/20 0.38
HTR2C P28335 1/20 0.36
DGKA P23743 1/20 0.36
TDP1 Q9NUW8 1/20 0.34
HTT P42858 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA1A P35348 1/20 0.33
EPHX1 P07099 1/20 0.33
PRSS1 P07477 1/20 0.32
PRSS2 P07478 1/20 0.32
PRSS3 P35030 1/20 0.32
ACHE P22303 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL97045 0.97 NAAA (0.50) NAAATSHRHSD17B10RAD52NPSR1
SCHEMBL8762400 0.97 NAAA (0.44) NAAATSHRHSD17B10RAD52NPSR1
SCHEMBL98427 0.97 NAAA (0.50) NAAATSHRHSD17B10RAD52NPSR1
SCHEMBL11235417 0.97 NAAA (0.50) NAAATSHRHSD17B10RAD52NPSR1
SCHEMBL11585668 0.97 NAAA (0.50) NAAATSHRHSD17B10RAD52NPSR1
SCHEMBL96893 0.97 NAAA (0.50) NAAATSHRHSD17B10RAD52NPSR1
SCHEMBL98407 0.94 TSHR (0.46) NAAATSHRHSD17B10RAD52NPSR1
Ethylene Glycol SCHEMBL9137199 0.92 NAAA (0.41) NAAATSHRHSD17B10RAD52NPSR1
SCHEMBL3520306 0.92 NAAA (0.41) NAAATSHRHSD17B10RAD52NPSR1
SCHEMBL11547288 0.90 NAAA (0.45) NAAATSHRHSD17B10RAD52NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 952 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260117456-A1 LCE-BASED ARTIFICIAL MUSCLE FIBER AND PREPARATION METHOD AND USE THEREOF NANJING DRUM TOWER HOSPITAL (CN) 2026-04-30 US claimed
EP-4731691-A1 CURABLE COMPOSITION HAVING AN ALDEHYDE-FUNCTIONAL POLYMER Sika Technology AG (CH) 2026-04-29 EP claimed
US-20260014091-A1 COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF OHIO STATE INNOVATION FOUNDATION (US) 2026-01-15 US claimed
EP-4642651-A1 PHOSPHINE OXIDE-BASED PHOTOINITIATORS ARKEMA France (FR) 2025-11-05 EP claimed
US-20250243370-A1 POLYDIMETHYLSILOXANE SUPERAMPHIPHOBIC COATING, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF Beijing Tsd Semiconductor Co., Ltd. (CN) 2025-07-31 US claimed
EP-3275911-B1 POLYMERIZABLE COMPOSITION, OPTICAL MEMBER, PLASTIC LENS, AND EYEGLASS LENS HOYA LENS THAILAND LTD (TH) 2025-07-02 EP claimed
WO-2025051416-A1 CROSSLINKABLE BASE FOR PRODUCING AN ANTI-CORROSION COATING FOR A METAL SURFACE, IN PARTICULAR FOR AERONAUTICS CY CERGY PARIS UNIVERSITE (FR) 2025-03-13 WO claimed
US-20250033015-A1 POLYDISULFIDE CORE-SHELL MICROCAPSULES FIRMENICH SA (CH) 2025-01-30 US claimed
WO-2024261009-A1 CURABLE COMPOSITION HAVING AN ALDEHYDE-FUNCTIONAL POLYMER SIKA TECHNOLOGY AG (CH) 2024-12-26 WO claimed
EP-4480978-A1 CURABLE COMPOSITION CONTAINING ALDEHYDE FUNCTIONAL POLYMER Sika Technology AG (CH) 2024-12-25 EP claimed
EP-2848641-B1 METHOD FOR PRODUCING RUBBER MOLDING NICHIAS CORP (JP) 2018-02-28 EP claimed
WO-2018035102-A1 THIOURETHANE POLYMERS, METHOD OF SYNTHESIS THEREOF AND USE IN FUSED FILAMENT FABRICATION PRINTING BOARD OF REGENTS, THE UNIVERSITY OF TEXAS (US) 2018-02-22 WO claimed
EP-3275911-A1 POLYMERIZABLE COMPOSITION, OPTICAL MEMBER, PLASTIC LENS, AND EYEGLASS LENS Hoya Lens Thailand Ltd. (TH) 2018-01-31 EP claimed
US-20150148495-A1 METHOD FOR PRODUCING RUBBER MOLDING NICHIAS CORPORATION (JP) 2015-05-28 US claimed
EP-2848641-A1 METHOD FOR PRODUCING RUBBER MOLDING Nichias Corporation (JP) 2015-03-18 EP claimed
US-8722810-B2 Modified high CIS conjugated diene copolymer and preparing method of the same CHI MEI CORPORATION (TW) 2014-05-13 US claimed
US-20130172492-A1 MODIFIED HIGH CIS CONJUGATED DIENE COPOLYMER AND PREPARING METHOD OF THE SAME CHI MEI CORPORATION (TW) 2013-07-04 US claimed
US-20070287033-A1 Magnetic recording medium FUJIFILM CORPORATION (JP) 2007-12-13 US claimed
US-6117923-A OXIDATION RESISTANCE. POLYMERIZING A NOVEL SULFUR-CONTAINING COMPOUND HAVING AN EPISULFIDE STRUCTURE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2000-09-12 US claimed
US-4093780-A ESTERS AND POLYESTERS OF THIOGLYCOLIC ACID NORANDA MINES LIMITED (CA) 1978-06-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260014091-A1 COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF ERBB3, ERBB2, EGFR NAAA 2378/4885TSHR 1318/4885HSD17B10 2242/4885
US-20260117456-A1 LCE-BASED ARTIFICIAL MUSCLE FIBER AND PREPARATION METHOD AND USE THEREOF MYLK2, MYH10, TNNC1 NAAA 3176/4885TSHR 745/4885HSD17B10 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.